Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
AI Guidelines for Physicians
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Neurology
•
Vascular Neurology
•
Invited Professor Series
Is perfusion imaging reliable in determining stroke infarct vs. area at risk?
Answer from: at Community Practice
It has not been studied in ICAD. More studies are needed to help elucidate this.
Sign in or Register to read more
Answer from: at Academic Institution
Yes, I use perfusion. However, I also emphasize on carefully examining the plain CT scan with ASPECTS windows, as it provides more definitive information.
Sign in or Register to read more
16097
20901
Related Questions
How do you distinguish between episodes of vascular steal and seizures in patients with an AVM?
What factors would influence your decision to use or avoid heparin bridging in patients with mechanical heart valves resuming anticoagulation after intracerebral hemorrhage?
How would you approach antithrombotic therapy in patients with acute ischemic infarcts and a non-occlusive intracranial thrombus?
How does the presence of signs of cerebral edema influence your decision for thrombolysis and endovascular thrombectomy?
In ischemic stroke patients with low LDL levels (<30-50 mg/dl), would you consider lowering LDL levels to lower values without concern for any side effects?
Do all patients referred for acute symptoms of TIA or minor stroke require additional imaging with CT/MR angiography, in addition to admission/observation?
How do you counsel patients on the outcomes of endovascular treatment of acute basilar artery occlusion?
How do you manage patients with embolic stroke of an undetermined source and a papillary fibroelastoma found on an echocardiogram?
How do you use aspirin in pre-symptomatic Sturge Weber patients?
What is the most updated consensus regarding the use of pill in the pocket oral anticoagulation in paroxysmal atrial fibrillation, and populations of patients who are most likely to be considered for enrollment in clinical trials?